丁香实验_LOGO
登录
提问
我要登录
|免费注册
点赞
收藏
wx-share
分享

Gastrointestinal System

互联网

3737
佚名

Pathophysiologic concepts
  Anorexia
  Constipation
  Diarrhea
  Dysphagia
  Jaundice
  Nausea
  Vomiting
Disorders
  Appendicitis
  Cholecystitis
  Cirrhosis
  Crohn's disease
  Diverticular disease
  Gastroesophageal reflux disease
  Hemorrhoids
  Hepatitis, nonviral
  Hepatitis, viral
  Hirschsprung's disease
  Hyperbilirubinemia
  Irritable bowel syndrome
  Liver failure
  Malabsorption
  Pancreatitis
  Peptic ulcer
  Ulcerative colitis

T he gastrointestinal (GI) system has the critical task of supplying essential nutrients to fuel all the physiologic and pathophysiologic activities of the body. Its functioning profoundly affects the quality of life through its impact on overall health. The GI system has two major components: the alimentary canal, or GI tract, and the accessory organs. A malfunction anywhere in the system can produce far-reaching metabolic effects, eventually threatening life itself.

The alimentary canal is a hollow muscular tube that begins in the mouth and ends at the anus. It includes the oral cavity, pharynx, esophagus, stomach, small intestine, and large intestine. Peristalsis propels the ingested material along the tract; sphincters prevent its reflux. Accessory glands and organs include the salivary glands, liver, biliary duct system (gallbladder and bile ducts), and pancreas.

Together, the GI tract and accessory organs serve two major functions: digestion (breaking down food and fluids into simple chemicals that can be absorbed into the bloodstream and transported throughout the body) and elimination of waste products from the body through defecation.

PATHOPHYSIOLOGIC CONCEPTS

Disorders of the GI system often manifest as vague, nonspecific complaints or problems that reflect disruption in one or more of the system's functions. For example, movement through the GI tract can be slowed, accelerated, or blocked, and secretion, absorption, or motility can be altered. As a result, one patient may present with several problems, the most common being anorexia, constipation, diarrhea, dysphagia, jaundice, nausea, and vomiting.

Anorexia

Anorexia is a loss of appetite or a lack of desire for food. Nausea, abdominal pain, and diarrhea may accompany it. Anorexia can result from dysfunction, such as cancer, heart disease, or renal disease, in the gastrointestinal system or other systems.

Normally, a physiologic stimulus is responsible for the sensation of hunger. Falling blood glucose levels stimulate the hunger center in the hypothalamus; rising blood fat and amino acid levels promote satiety. Hunger is also stimulated by contraction of an empty stomach and suppressed when the GI tract becomes distended, possibly as a result of stimulation of the vagus nerve. Sight, touch, and smell play subtle roles in controlling the appetite center.

In anorexia, the physiologic stimuli are present but the person has no appetite or desire to eat. Slow gastric emptying or gastric stasis can cause anorexia. High levels of neurotransmitters such as serotonin (may contribute satiety) and excess cortisol levels (may suppress hypothalamic control of hunger) have been implicated.

Constipation

Constipation is hard stools and difficult or infrequent defecation, as defined by a decrease in the number of stools per week. It is defined individually, because normal bowel habits range from 2 to 3 episodes of stool passage per day to one per week. Causes of constipation include dehydration, consumption of a low bulk diet, a sedentary lifestyle, lack of regular exercise, and frequent repression of the urge to defecate.

When a person is dehydrated or delays defecation, more fluid is absorbed from the intestine, the stool becomes harder, and constipation ensues. High fiber diets cause water to be drawn into the stool by osmosis, thereby keeping stool soft and encouraging movement through the intestine. High fiber diets also causes intestinal dilation, which stimulates peristalsis. Conversely, a low fiber diet would contribute to constipation.

AGE ALERT The elderly typically experience a decrease in intestinal motility in addition to a slowing and dulling of neural impulses in the GI tract. Many older persons restrict fluid intake to prevent waking at night to use the bathroom or because of a fear of incontinence. This places them at risk for dehydration and constipation.

A sedentary lifestyle or lack of exercise can cause constipation because exercise stimulates the gastrointestinal tract and promotes defecation. Antacids, opiates, and other drugs that inhibit bowel motility also lead to constipation.

Stress stimulates the sympathetic nervous system, and GI motility slows. Absence or degeneration in the neural pathways of the large intestine also contributes to constipation. And other conditions, such as spinal cord trauma, multiple sclerosis, intestinal neoplasms, and hypothyroidism, can cause constipation.

Diarrhea

Diarrhea is an increase in the fluidity or volume of feces and the frequency of defecation. Factors that affect stool volume and consistency include water content of the colon and the presence of unabsorbed food, unabsorbable material, and intestinal secretions. Large-volume diarrhea is usually the result of an excessive amount of water, secretions, or both in the intestines. Small-volume diarrhea is usually caused by excessive intestinal motility. Diarrhea may also be caused by a parasympathetic stimulation of the gut initiated by psychological factors such as fear or stress.

The three major mechanisms of diarrhea are osmosis, secretion, and motility:

  • Osmotic diarrhea: The presence of nonabsorbable substance, such as synthetic sugar, or increased numbers of osmotic particles in the intestine, increases osmotic pressure and draws excess water into the intestine, thereby increasing the weight and volume of the stool.
  • Secretory diarrhea: A pathogen or tumor irritates the muscle and mucosal layers of the intestine. The consequent increase in motility and secretions (water, electrolytes, and mucus) results in diarrhea.
  • Motility diarrhea: Inflammation, neuropathy, or obstruction causes a reflex increase in intestinal motility that may expel the irritant or clear the obstruction.

Dysphagia

Dysphagia ― difficulty swallowing ― can be caused by a mechanical obstruction of the esophagus or by impaired esophageal motility secondary to another disorder. Mechanical obstruction is characterized as intrinsic or extrinsic.

Intrinsic obstructions originate in the esophagus itself. Causes of intrinsic tumors include tumors, strictures, and diverticular herniations. Extrinsic obstructions originate outside of the esophagus and narrow the lumen by exerting pressure on the esophageal wall. Most extrinsic obstruction results from a tumor.

Distention and spasm at the site of the obstruction during swallowing may cause pain. Upper esophageal obstruction causes pain 2 to 4 seconds after swallowing; lower esophageal obstructions, 10 to 15 seconds after swallowing. If a tumor is present, dysphagia begins with difficulty swallowing solids and eventually progresses to difficulty swallowing semi-solids and liquids. Impaired motor function makes both liquids and solids difficult to swallow.

WHAT HAPPENS IN SWALLOWING

Before peristalsis can begin, the neural pattern to initiate swallowing, illustrated here, must occur:

  • Food reaching the back of the mouth stimulates swallowing receptors that surround the pharyngeal opening.
  • The receptors transmit impulses to the brain by way of the sensory portions of the trigeminal (V) and glossopharyngeal (IX) nerves.
  • The brain's swallowing center relays motor impulses to the esophagus by way of the trigeminal (V), glossopharyngeal (IX), vagus (X), and hypoglossal (XII) nerves.
  • Swallowing occurs.
<center></center>

Neural or muscular disorders can also interfere with voluntary swallowing or peristalsis. This is known as functional dysphagia. Causes of functional dysphagia include dermatomyositis, cerebrovascular accident, Parkinson's disease, or achalasia. (See What happens in swallowing .) Malfunction of the upper esophageal striated muscles interferes with the voluntary phase of swallowing.

In achalasia, the esophageal ganglionic cells are thought to have degenerated, and the cardiac sphincter of the stomach cannot relax. The lower end of the esophagus loses neuromuscular coordination and muscle tone, and food accumulates, causing hypertrophy and dilation. Eventually, accumulated food raises the hydrostatic pressure and forces the sphincter open, and small amounts of food slowly move into the stomach.

Jaundice

Jaundice ― yellow pigmentation of the skin and sclera ― is caused by an excess accumulation of bilirubin in the blood. Bilirubin, a product of red blood cell breakdown, accumulates when production exceeds metabolism and excretion. This imbalance can result from excessive release of bilirubin precursors into the bloodstream or from impairment of its hepatic uptake, metabolism, or excretion. (See Jaundice: Impaired bilirubin metabolism .) Jaundice occurs when bilirubin levels exceed 34 to 43 mmol/L (2.0 to 2.5 mg/dl), which is about twice the upper limit of the normal range. Lower levels of bilirubin may cause detectable jaundice in patients with fair skin, and jaundice may be difficult to detect in patients with dark skin.

CULTURAL DIVERSITY Jaundice in dark-skinned persons may appear as yellow staining in the sclera, hard palate, and palmar or plantar surfaces.

The three main types of jaundice are hemolytic jaundice, hepatocellular jaundice, or obstructive jaundice:

  • Hemolytic jaundice: When red blood cell lysis exceeds the liver's capacity to conjugate bilirubin (binding bilirubin to a polar group makes it water soluble and able to be excreted by the kidneys), hemolytic jaundice occurs. Causes include transfusion reactions, sickle cell anemia, thalassemia, and autoimmune disease.
  • Hepatocellular jaundice: Hepatocyte dysfunction limits uptake and conjugation of bilirubin. Liver dysfunction can occur in hepatitis, cancer, cirrhosis, or congenital disorders, and some drugs can cause it.
  • Obstructive jaundice: When the flow of bile out of the liver (through the hepatic duct) or through the bile duct is blocked, the liver can conjugate bilirubin, but the bilirubin can't reach the small intestine. Blockage of the hepatic duct by stones or a tumor is considered an intrahepatic cause of obstructive jaundice. A blocked bile duct is an extrahepatic cause. Gallstones or a tumor may obstruct the bile duct.

Nausea

Nausea is feeling the desire to vomit. It may occur independently of vomiting, or it may precede or accompany it. Specific neural pathways have not been identified, but increased salivation, diminished functional activities of the stomach, and altered small intestinal motility have been associated with nausea. Nausea may also be stimulated by high brain centers.

Vomiting

Vomiting is the forceful oral expulsion of gastric contents. The gastric musculature provides the ejection force. The gastric fundus and gastroesophageal sphincter relax, and forceful contractions of the diaphragm and abdominal wall muscles increase intraabdominal pressure. This, combined with the annular contraction of the gastric pylorus, forces gastric contents into the esophagus. Increased intrathoracic pressure then moves the gastric content from the esophagus to the mouth.

Vomiting is controlled by two centers in the medulla: the vomiting center and the chemoreceptor trigger zone. The vomiting center initiates the actual act of vomiting. It is stimulated by the gastrointestinal tract, from higher brainstem and cortical centers, and from the chemoreceptor trigger zone. The chemoreceptor trigger zone can't induce vomiting by itself. Various stimuli or drugs activate the zone, such as apomorphine, levodopa, digitalis, bacterial toxins, radiation, and metabolic abnormalities. The activated zone sends impulses to the medullary vomiting center, and the following sequence begins:

  • The abdominal muscles and diaphragm contract.
  • Reverse peristalsis begins, causing intestinal material to flow back into the stomach, distending it.
  • The stomach pushes the diaphragm into the thoracic cavity, raising the intrathoracic pressure.
  • The pressure forces the upper esophageal sphincter open, the glottis closes, and the soft palate blocks the nasopharynx.
  • The pressure also forces the material up through the sphincter and out through the mouth.

JAUNDICE: IMPAIRED BILIRUBIN METABOLISM

Jaundice occurs in three forms: prehepatic, hepatic, and posthepatic. In all three, bilirubin levels in the blood increase.

PREHEPATIC JAUNDICE

Certain conditions and disorders, such as transfusion reactions and sickle cell anemia, cause massive hemolysis.

  • Red blood cells rupture faster than the liver can conjugate bilirubin.
  • Large amounts of unconjugated bilirubin pass into the blood.
  • Intestinal enzymes convert bilirubin to water-soluble urobilinogen for excretion in urine and stools. (Unconjugated bilirubin is insoluble in water, so it can't be directly secreted in urine.)
<center></center>

HEPATIC JAUNDICE

The liver becomes unable to conjugate or excrete bilirubin, leading to increased blood levels of conjugated and unconjugated bilirubin. This occurs in such disorders as hepatitis, cirrhosis, and metastatic cancer, and during prolonged use of drugs metabolized by the liver.

<center></center>

POSTHEPATIC JAUNDICE

In biliary and pancreatic disorders, bilirubin forms at its normal rate.

  • Inflammation, scar tissue, tumor, or gallstones block the flow of bile into the intestines.
  • Water-soluble conjugated bilirubin accumulates in the blood.
  • The bilirubin is excreted in the urine.
<center></center>

Both nausea and vomiting are manifestations of other disorders, such as acute abdominal emergencies, infections of the intestinal tract, central nervous system disorders, myocardial infarction, congestive heart failure, metabolic and endocrinologic disorders, or as the side effect of many drugs. Vomiting may also be psychogenic, resulting from emotional or psychological disturbance.

DISORDERS

Appendicitis

The most common major surgical disease, appendicitis is inflammation and obstruction of the vermiform appendix. Appendicitis may occur at any age and affects both sexes equally; however, between puberty and age 25, it's more prevalent in men. Since the advent of antibiotics, the incidence and the death rate of appendicitis have declined; if untreated, this disease is invariably fatal.

Causes

Causes may include:

  • mucosal ulceration
  • fecal mass
  • stricture
  • barium ingestion
  • viral infection.

Pathophysiology

Mucosal ulceration triggers inflammation, which temporarily obstructs the appendix. The obstruction blocks mucus outflow. Pressure in the now distended appendix increases, and the appendix contracts. Bacteria multiply, and inflammation and pressure continue to increase, restricting blood flow to the organ and causing severe abdominal pain.

Signs and symptoms

Signs and symptoms may include:

  • abdominal pain caused by inflammation of the appendix and bowel obstruction and distention
  • anorexia after the onset of pain
  • nausea or vomiting caused by the inflammation
  • low-grade temperature from systemic manifestation of inflammation and leukocytosis
  • tenderness from inflammation.

Complications

Complications may include:

  • wound infection
  • intraabdominal abscess
  • fecal fistula
  • intestinal obstruction
  • incisional hernia
  • peritonitis
  • death.

Diagnosis

  • White blood cell count is moderately high with an increased number of immature cells.
  • X-ray with radiographic contrast agent reveals failure of the appendix to fill with contrast.

Treatment

Treatment may include:

  • maintenance of NPO status until surgery
  • high Fowler's position to aid in pain relief
  • GI intubation for decompression
  • appendectomy
  • antibiotics to treat infection if peritonitis occurs
  • parental replacement of fluid and electrolytes to reverse possible dehydration resulting from surgery or nausea and vomiting.

Cholecystitis

Cholecystitis ― acute or chronic inflammation causing painful distention of the gallbladder ― is usually associated with a gallstone impacted in the cystic duct. Cholecystitis accounts for 10% to 25% of all patients requiring gallbladder surgery. The acute form is most common among middle-aged women; the chronic form, among the elderly. The prognosis is good with treatment.

Causes

  • Gallstones (the most common cause)
  • Poor or absent blood flow to the gallbladder
  • Abnormal metabolism of cholesterol and bile salts.

Pathophysiology

In acute cholecystitis, inflammation of the gallbladder wall usually develops after a gallstone lodges in the cystic duct. (See Understanding gallstone formation .) When bile flow is blocked, the gallbladder becomes inflamed and distended. Bacterial growth, usually Escherichia coli , may contribute to the inflammation. Edema of the gallbladder (and sometimes the cystic duct) obstructs bile flow, which chemically irritates the gallbladder. Cells in the gallbladder wall may become oxygen starved and die as the distended organ presses on vessels and impairs blood flow. The dead cells slough off, and an exudate covers ulcerated areas, causing the gallbladder to adhere to surrounding structures.

Signs and symptoms

  • Acute abdominal pain in the right upper quadrant that may radiate to the back, between the shoulders, or to the front of the chest secondary to inflammation and irritation of nerve fibers
  • Colic due to the passage of gallstones along the bile duct
  • Nausea and vomiting triggered by to the inflammatory response
  • Chills related to fever
  • Low-grade fever secondary to inflammation
  • Jaundice from obstruction of the common bile duct by stones.

Complications

  • Perforation and abscess formation
  • Fistula formation
  • Gangrene
  • Empyema
  • Cholangitis
  • Hepatitis
  • Pancreatitis
  • Gallstone ileus
  • Carcinoma.

Diagnosis

  • X-ray reveals gallstones if they contain enough calcium to be radiopaque; also helps disclose porcelain gallbladder (hard, brittle gall bladder due to calcium deposited in wall), limy bile, and gallstone ileus.
  • Ultrasonography detects gallstones as small as 2 mm and distinguishes between obstructive and nonobstructive jaundice.
  • Technetium-labeled scan indicates reveals cystic duct obstruction and acute or chronic cholecystitis if ultrasound doesn't visualize the gallbladder.
  • Percutaneous transhepatic cholangiography or cholesystoscopy supports the diagnosis of obstructive jaundice and reveals calculi in the ducts.
  • Levels of serum alkaline phosphate, lactate dehydrogenase, aspartate aminotransferase, and total bilirubin are high; serum amylase slightly elevated; and icteric index elevated.
  • White blood cell counts are slightly elevated during cholecystitis attack.

Treatment

  • Cholecystectomy to surgically remove the inflamed gallbladder
  • Choledochostomy to surgically create an opening into the common bile duct for drainage
  • Percutaneous transhepatic cholecytostomy
  • Endoscopic retrograde cholangiopancreatography for removal of gallstones
  • Lithotripsy to break up gallstones and relieve obstruction
  • Oral chenodeoxycholic acid or ursodeoxycholic acid to dissolve stones
  • Low fat diet to prevent attacks
  • Vitamin K to relieve itching, jaundice, and bleeding tendencies due to vitamin K deficiencies
  • Antibiotics for use during acute attack for treatment of infection
  • Nasogastric tube insertion during acute attack for abdominal decompression.

Cirrhosis

Cirrhosis is a chronic disease characterized by diffuse destruction and fibrotic regeneration of hepatic cells. As necrotic tissue yields to fibrosis, this disease damages liver tissue and normal vasculature, impairs blood and lymph flow, and ultimately causes hepatic insufficiency. It's twice as common in men as in women, and is especially prevalent among malnourished persons over the age of 50 with chronic alcoholism. Mortality is high; many patients die within 5 years of onset.

UNDERSTANDING GALLSTONE FORMATION

Abnormal metabolism of cholesterol and bile salts plays an important role in gallstone formation. The liver makes bile continuously. The gall bladder concentrates and stores it until the duodenum signals it needs it to help digest fat. Changes in the composition of bile may allow gallstones to form. Changes to the absorptive ability of the gallbladder lining may also contribute to gallstone formation.

TOO MUCH CHOLESTEROL

Certain conditions, such as age, obesity, and estrogen imbalance, cause the liver to secrete bile that's abnormally high in cholesterol or lacking the proper concentration of bile salts. The coronary arteries are made of three layers: intima (the innermost layer, media (the middle layer), and adventitia (the outermost layer).

<center></center>

INSIDE THE GALLBLADDER

When the gallbladder concentrates this bile, inflammation may occur. Excessive reabsorption of water and bile salts makes the bile less soluble. Cholesterol, calcium, and bilirubin precipitate into gallstones.

Fat entering the duodenum causes the intestinal mucosa to secrete the hormone cholecystokinin, which stimulates the gallbladder to contract and empty. If a stone lodges in the cystic duct, the gallbladder contracts but can't empty.

<center></center>

JAUNDICE, IRRITATION, INFLAMMATION

If a stone lodges in the common bile duct, the bile can't flow into the duodenum. Bilirubin is absorbed into the blood and causes jaundice.

Biliary narrowing and swelling of the tissue around the stone can also cause irritation and inflammation of the common bile duct.

<center></center>

UP THE BILIARY TREE

Inflammation can progress up the biliary tree into any of the bile ducts. This causes scar tissue, fluid accumulation, cirrhosis, portal hypertension, and bleeding.

<center></center>

Causes

Cirrhosis may be a result of a wide range of diseases. The following clinical types of cirrhosis reflect its diverse etiology.

Hepatocellular disease. This group includes the following disorders:

  • Postnecrotic cirrhosis accounts for 10% to 30% of patients and stems from various types of hepatitis (such as Types A, B, C, D viral hepatitis) or toxic exposures.
  • La?nnec's cirrhosis, also called portal, nutritional, or alcoholic cirrhosis, is the most common type and is primarily caused by hepatitis C. Liver damage results from malnutrition (especially dietary protein) and chronic alcohol ingestion. Fibrous tissue forms in portal areas and around central veins.
  • Autoimmune disease such as sarcoidosis or chronic inflammatory bowel disease may cause cirrhosis.

Cholestatic diseases. This group includes diseases of the biliary tree (biliary cirrhosis resulting from bile duct diseases suppressing bile flow) and sclerosing cholangitis.

Metabolic diseases. This group includes disorders such as Wilson's disease, alpha 1 -antitrypsin, and hemochromatosis (pigment cirrhosis).

Other types of cirrhosis. Other types of cirrhosis include Budd-Chiari syndrome (epigastric pain, liver enlargement, and ascites due to hepatic vein obstruction), cardiac cirrhosis, and cryptogenic cirrhosis. Cardiac cirrhosis is rare; the liver damage results from right heart failure. Cryptogenic refers to cirrhosis of unknown etiology.

Pathophysiology

Cirrhosis begins with hepatic scarring or fibrosis. The scar begins as an increase in extracellular matrix components ― fibril-forming collagens, proteoglycans, fibronectin, and hyaluronic acid. The site of collagen deposition varies with the cause. Hepatocyte function is eventually impaired as the matrix changes. Fat-storing cells are believed to be the source of the new matrix components. Contraction of these cells may also contribute to disruption of the lobular architecture and obstruction of the flow of blood or bile. Cellular changes producing bands of scar tissue also disrupt the lobular structure.

Signs and symptoms

The following are signs and symptoms of the early stages:

  • anorexia from distaste for certain foods
  • nausea and vomiting from inflammatory response and systemic effects of liver inflammation
  • diarrhea from malabsorption
  • dull abdominal ache from liver inflammation.

The following are signs and symptoms of the late stages:

  • respiratory ― pleural effusion, limited thoracic expansion due to abdominal ascites; interferes with efficient gas exchange and causes hypoxia
  • central nervous system ― progressive signs or symptoms of hepatic encephalopathy, including lethargy, mental changes, slurred speech, asterixis, peripheral neuritis, paranoia, hallucinations, extreme obtundation, and coma ― secondary to loss of ammonia to urea conversion and consequent delivery of toxic ammonia to the brain
  • hematologic ― bleeding tendencies (nosebleeds, easy bruising, bleeding gums), anemia resulting from thrombocytopenia (secondary to splenomegaly and decreased vitamin K absorption), splenomegaly, and portal hypertension
  • endocrine ― testicular atrophy, menstrual irregularities, gynecomastia, and loss of chest and axillary hair from decreased hormone metabolism
  • skin ― severe pruritus secondary to jaundice from bilirubinemia; extreme dryness and poor tissue turgor related to malnutrition; abnormal pigmentation, spider angiomas, palmar erythema, and jaundice related to impaired hepatic function
  • hepatic ― jaundice from decreased bilirubin metabolism; hepatomegaly secondary to liver scarring and portal hypertension; ascites and edema of the legs from portal hypertension and decreased plasma proteins; hepatic encephalopathy from ammonia toxicity; and hepatorenal syndrome from advanced liver disease and subsequent renal failure
  • miscellaneous ― musty breath secondary to ammonia build up; enlarged superficial abdominal veins due to portal hypertension; pain in the right upper abdominal quadrant that worsens when patient sits up or leans forward, due to inflammation and irritation of area nerve fibers; palpable liver or spleen due to organomegaly; temperature of 101° to 103° F (38° to 39° C) due to inflammatory response; pain and increased temperature from liver inflammation
  • hemorrhage from esophageal varices resulting from portal hypertension. (See What happens in portal hypertension .)

Complications

Complications may include:

  • ascites
  • portal hypertension
  • jaundice
  • coagulopathy
  • hepatic encephalopathy
  • bleeding esophageal varices; acute GI bleeding
  • liver failure
  • renal failure.

Diagnosis

  • Liver biopsy reveals tissue destruction and fibrosis.
  • Abdominal X-ray shows enlarged liver, cysts, or gas within the biliary tract or liver, liver calcification, and massive fluid accumulation (ascites).
  • Computed tomography and liver scans show liver size, abnormal masses, and hepatic blood flow and obstruction.
  • Esophagogastroduodenoscopy reveals bleeding esophageal varices, stomach irritation or ulceration, or duodenal bleeding and irritation.
  • Blood studies reveal elevated liver enzymes, total serum bilirubin, and indirect bilirubin; decreased total serum albumin and protein; prolonged prothrombin time; decreased hemoglobin, hematocrit, and serum electrolytes; and deficiency of vitamins A, C, and K.
  • Urine studies show increased bilirubin and urobilirubinogen.
  • Fecal studies show decreased fecal urobilirubinogen.

Treatment

  • Vitamins and nutritional supplements to help heal damaged liver cells and improve nutritional status
  • Antacids to reduce gastric distress and decrease the potential for gastrointestinal bleeding
  • Potassium-sparing diuretics to reduce fluid accumulation
  • Vasopressin to treat esophageal varices
  • Esophagogastric intubation with multilumen tubes to control bleeding from esophageal varices or other hemorrhage sites by using balloons to exert pressure on bleeding site.
  • Gastric lavage until the contents are clear; with antacids and histamine antagonists if bleeding is secondary to a gastric ulcer
  • Esophageal balloon tamponade to compress bleeding vessels and stop blood loss from esophageal varices
  • Paracentesis to relieve abdominal pressure and remove ascitic fluid
  • Surgical shunt placement to divert ascites into venous circulation, leading to weight loss, increased abdominal girth, increased sodium excretion from the kidneys, and improved urine output
  • Sclerosing agents injected into oozing vessels to cause clotting and sclerosis
  • Insertion of portosystemic shunts to control bleeding from esophageal varices and decrease portal hypertension (diverts a portion of the portal vein blood flow away from the liver; seldom performed).

Crohn's disease

Crohn's disease, also known as regional enteritis or granulomatous colitis, is inflammation of any part of the gastrointestinal tract (usually the proximal portion of the colon and less commonly the terminal ileum), extending through all layers of the intestinal wall. It may also involve regional lymph nodes and the mesentery. Crohn's disease is most prevalent in adults ages 20 to 40.

WHAT HAPPENS IN PORTAL HYPERTENSION

Portal hypertension (elevated pressure in the portal vein) occurs when blood flow meets increased resistance. This common result of cirrhosis may also stem from mechanical obstruction and occlusion of the hepatic veins (Budd-Chiari syndrome).

As the pressure in the portal vein rises, blood backs up into the spleen and flows through collateral channels to the venous system, bypassing the liver. Thus, portal hypertension causes:

  • splenomegaly with thrombocytopenia
  • dilated collateral veins (esophageal varices, hemorrhoids, or prominent abdominal veins)
  • ascites.

In many patients, the first sign of portal hypertension is bleeding esophageal varices (dilated tortuous veins in the submucosa of the lower esophagus). Esophageal varices commonly cause massive hematemesis, requiring emergency care to control hemorrhage and prevent hypovolemic shock.

<center></center>


CULTURAL DIVERSITY Crohn's disease is two to three times more common in Ashkenazic Jews and least common in African Americans. Up to 20% of patients have a positive family history for the disease.


BOWEL CHANGES IN CROHN'S DISEASE

As Crohn's disease progresses, fibrosis thickens the bowel wall and narrows the lumen. Narrowing ― or stenosis ― can occur in any part of the intestine and cause varying degrees of intestinal obstruction. At first, the mucosa may appear normal, but as the disease progresses it takes on a “cobblestone” appearance as shown.

<center></center>

Causes

The exact cause is unknown but the following conditions may contribute:

Pathophysiology

Whatever the cause of Crohn's disease, inflammation spreads slowly and progressively. Enlarged lymph nodes block lymph flow in the submucosa. Lymphatic obstruction leads to edema, mucosal ulceration and fissures, abscesses, and sometimes granulomas. Mucosal ulcerations are called “skipping lesions'' because they are not continuous, as in ulcerative colitis.

Oval, elevated patches of closely packed lymph follicles ― called Peyer's patches ― develop in the lining of the small intestine. Subsequent fibrosis thickens the bowel wall and causes stenosis, or narrowing of the lumen. (See Bowel changes in Crohn's disease .) The serous membrane becomes inflamed (serositis), inflamed bowel loops adhere to other diseased or normal loops, and diseased bowel segments become interspersed with healthy ones. Finally, diseased parts of the bowel become thicker, narrower, and shorter.

Signs and symptoms

Signs and symptoms include:

Complications

Complications may include:

Diagnosis

Treatment

Diverticular disease

In diverticular disease, bulging pouches (diverticula) in the gastrointestinal wall push the mucosal lining through the surrounding muscle. Although the most common site for diverticula is in the sigmoid colon, they may develop anywhere, from the proximal end of the pharynx to the anus. Other typical sites include the duodenum, near the pancreatic border or the ampulla of Vater, and the jejunum.

CULTURAL DIVERSITY Diverticular disease is common in Western countries, suggesting that a low-fiber diet reduces stool bulk and leads to excessive colonic motility. This consequent increased intraluminal pressure causes herniation of the mucosa.

Diverticular disease of the stomach is rare and is usually a precursor of peptic or neoplastic disease. Diverticular disease of the ileum (Meckel's diverticulum) is the most common congenital anomaly of the gastrointestinal tract.

PATHOGENESIS OF DIVERTICULAR DISEASE

The etiology of diverticular disease hasn't been determined. It's thought to arise from a disordered colonic motility pattern. These diagrams compare normal and abnormal patterns.

<center></center>

Diverticular disease has two clinical forms:

AGE ALERT Diverticular disease is most prevalent in men over age 40 and persons who eat a low fiber diet. More than half of patients older than 50 years have colonic diverticula.

Causes

Pathophysiology

Diverticula probably result from high intraluminal pressure on an area of weakness in the gastrointestinal wall, where blood vessels enter. (See Pathogenesis of diverticular disease .) Diet may be a contributing factor, because insufficient fiber reduces fecal residue, narrows the bowel lumen, and leads to high intra-abdominal pressure during defecation.

In diverticulitis, retained undigested food and bacteria accumulates in the diverticular sac. This hard mass cuts off the blood supply to the thin walls of the sac, making them more susceptible to attack by colonic bacteria. Inflammation follows and may leading to perforation, abscess, peritonitis, obstruction, or hemorrhage. Occasionally, the inflamed colon segment may adhere to the bladder or other organs and cause a fistula.

Signs and symptoms

Typically the patient with diverticulosis is asymptomatic and will remain so unless diverticulitis develops.

Mild diverticulitis. In mild diverticulitis, signs and symptoms include:

Severe diverticulitis. In severe diverticulitis, signs and symptoms include:

Chronic diverticulitis. In chronic diverticulitis, signs and symptoms include:

Diagnosis

Treatment

Gastroesophageal reflux disease

Popularly known as heartburn, gastroesophageal reflux disease (GERD) refers to backflow of gastric or duodenal contents or both into the esophagus and past the lower esophageal sphincter (LES), without associated belching or vomiting. The reflux of gastric contents causes acute epigastric pain, usually after a meal. The pain may radiate to the chest or arms. It commonly occurs in pregnant or obese persons. Lying down after a meal also contributes to reflux.

Causes

Causes of GERD include:

HOW HEARTBURN OCCURS

Hormonal fluctuations, mechanical stress, and the effects of certain foods and drugs can lower esophageal sphincter (LES) pressure. When LES pressure falls and intraabdominal or intragastric pressure rises, the normally contracted LES relaxes inappropriately and allows reflux of gastric acid or bile secretions into the lower esophagus. There, the reflux irritates and inflames the esophageal mucosa, causing pyrosis.

Persistent inflammation can cause LES pressure to decrease even more and may trigger a recurrent cycle of reflux and pyrosis.

Pathophysiology

Normally, the LES maintains enough pressure around the lower end of the esophagus to close it and prevent reflux. Typically the sphincter relaxes after each swallow to allow food into the stomach. In GERD, the sphincter does not remain closed (usually due to deficient LES pressure or pressure within the stomach exceeding LES pressure) and the pressure in the stomach pushes stomach contents into the esophagus. The high acidity of the stomach contents causes pain and irritation when it enters the esophagus. (See How heartburn occurs .)

Signs and symptoms

Complications

Diagnosis

Diagnostic tests are aimed at determining the underlying cause of GERD:

Treatment

Hemorrhoids

Hemorrhoids are varicosities in the superior or inferior hemorrhoidal venous plexus. Dilation and enlargement of the superior plexus of the superior hemorrhoidal veins above the dentate line cause internal hemorrhoids. Enlargement of the plexus of the inferior hemorrhoidal veins below the dentate line causes external hemorrhoids, which may protrude from the rectum. Hemorrhoids occur in both sexes. Incidence is generally highest between ages 20 and 50.

Causes

Causes may include:

Pathophysiology

Hemorrhoids result from activities that increase intravenous pressure, causing distention and engorgement. Predisposing factors include prolonged sitting, straining at defecation, constipation, low-fiber diet, pregnancy, and obesity. Other factors include hepatic disease, such as cirrhosis, amebic abscesses, or hepatitis; alcoholism; and anorectal infections.

Hemorrhoids are classified as first, second, third, or fourth degree, depending on their severity. First-degree hemorrhoids are confined to the anal canal. Second-degree hemorrhoids prolapse during straining but reduce spontaneously. Third-degree hemorrhoids are prolapsed hemorrhoids that require manual reduction after each bowel movement. Fourth-degree hemorrhoids are irreducible. Signs and symptoms vary accordingly.

Signs and symptoms

Complications

Diagnosis

Treatment

Treatment depends on the type and severity of the hemorrhoids:

Hepatitis, nonviral

Nonviral hepatitis is an inflammation of the liver that usually results from exposure to certain chemicals or drugs. Most patients recover from this illness, although a few develop fulminating hepatitis or cirrhosis.

Causes

Pathophysiology

Various hepatotoxins ― such as carbon tetrachloride, acetaminophen, trichloroethylene, poisonous mushrooms, vinyl chloride ― can cause hepatitis. After exposure to these agents, hepatic cellular necrosis, scarring, Kupffer cell hyperplasia, and infiltration by mononuclear phagocytes occur with varying severity. Alcohol, anoxia, and preexisting liver disease exacerbate the effects of some toxins.

Drug-induced (idiosyncratic) hepatitis may begin with a hypersensitivity reaction unique to the individual, unlike toxic hepatitis, which appears to affect all exposed people indiscriminately. Among possible causes are niacin, halothane, sulfonamides, isoniazid, acetaminophen, methyldopa, and phenothiazines (cholestasis-induced hepatitis). Symptoms of hepatic dysfunction may appear at any time during or after exposure to these drugs, but it usually manifests after 2 to 5 weeks of therapy.

Signs and symptoms

Signs and symptoms include:

Complications

Diagnosis

Treatment

Treatment includes:

Hepatitis, viral

Viral hepatitis is a common infection of the liver, resulting in hepatic cell destruction, necrosis, and autolysis. In most patients, hepatic cells eventually regenerate with little or no residual damage. However, old age and serious underlying disorders make complications more likely. The prognosis is poor if edema and hepatic encephalopathy develop.

Five major forms of hepatitis are currently recognized:

Causes

Pathophysiology

Hepatic damage is usually similar in all types of viral hepatitis. Varying degrees of cell injury and necrosis occur.

On entering the body, the virus causes hepatocyte injury and death, either by directly killing the cells or by activating inflammatory and immune reactions. The inflammatory and immune reactions will, in turn, injure or destroy hepatocytes by lysing the infected or neighboring cells. Later, direct antibody attack against the viral antigens causes further destruction of the infected cells. Edema and swelling of the interstitium lead to collapse of capillaries and decreased blood flow, tissue hypoxia, and scarring and fibrosis.

Signs and symptoms

Signs and symptoms reflect the stage of the disease.

Prodromal stage. Signs and symptoms of the prodromal stage include:

VIRAL HEPATITIS FROM A TO E

This chart compares the features of each type of viral hepatitis that has been characterized. Other types are emerging.

FEATURE   HEPATITIS A   HEPATITIS B   HEPATITIS C   HEPATITIS D   HEPATITIS E
Incubation   15 to 45 days   30 to 180 days   15 to 160 days   14 to 64 days   14 to 60 days

Onset   Acute   Insidious   Insidious   Acute and chronic   Acute

Age group most affected   Children, young adults   Any age   More common in adults   Any age   Ages 20 to 40

Transmission   Fecal-oral, sexual (especially oral-anal contact), nonpercutaneous (sexual, maternal- neonatal), percutaneous (rare)   Blood-borne; parenteral route, sexual, maternal- neonatal; virus is shed in all body fluids   Blood-borne; parenteral route   Parenteral route; most people infected with hepatitis D are also infected with hepatitis B   Primarily fecal-oral

Severity   Mild   Often severe   Moderate   Can be severe and lead to fulminant hepatitis   Highly virulent with common progression to fulminant hepatitis and hepatic failure, especially in pregnant patients

Prognosis   Generally good   Worsens with age and debility   Moderate   Fair, worsens in chronic cases; can lead to chronic hepatitis D and chronic liver disease   Good unless pregnant

Progression to chronicity   None   Occasional   10% to 50% of cases   Occasional   None

Clinical stage. Signs and symptoms of the clinical stage include:

Recovery stage. The patient's symptoms subside and appetite returns.

Complications

Diagnosis

Treatment

Hirschsprung's disease

Hirschsprung's disease, also called congenital megacolon and congenital aganglionic megacolon, is a congenital disorder of the large intestine, characterized by absence or marked reduction of parasympathetic ganglion cells in the colorectal wall. Hirschsprung's disease appears to be a familial, congenital defect, occurring in 1 in 2,000 to 1 in 5,000 live births. It's up to seven times more common in males than in females (although the aganglionic segment is usually shorter in males) and is most prevalent in whites. Total aganglionosis affects both sexes equally. Females with Hirschsprung's disease are at higher risk for having affected children. This disease usually coexists with other congenital anomalies, particularly trisomy 21 and anomalies of the urinary tract such as megaloureter.

Without prompt treatment, an infant with colonic obstruction may die within 24 hours from enterocolitis that leads to severe diarrhea and hypovolemic shock. With prompt treatment, prognosis is good.

Cause

Pathophysiology

In Hirschsprung's disease, parasympathetic ganglion cells in the colorectal wall are absent or markedly reduced in number. The aganglionic bowel segment contracts without the reciprocal relaxation needed to propel feces forward. Impaired intestinal motility causes severe, intractable constipation. Colonic obstruction can ensue, causing bowel dilation and subsequent occlusion of surrounding blood and lymphatics. The ensuing mucosal edema, ischemia, and infarction draw large amounts of fluid into the bowel, causing copious amounts of liquid stool. Continued infarction and destruction of the mucosa can lead to infection and sepsis.

Signs and symptoms

In the newborn, signs and symptoms include:

In children, signs and symptoms include:

In adults, signs and symptoms (occurs rarely and is more prevalent in men) include:

Complications

Diagnosis

Treatment

Treatment may include:

Hyperbilirubinemia

Hyperbilirubinemia, also called neonatal jaundice, is the result of hemolytic processes in the newborn marked by elevated serum bilirubin levels and mild jaundice. It can be physiologic (with jaundice the only symptom) or pathologic (resulting from an underlying disease).

Physiologic jaundice generally develops 24 to 48 hours after birth and disappears by day 7 in full term babies and by day 9 or 10 in premature infants. Serum unconjugated bilirubin levels do not exceed 12mg/dl. Pathologic jaundice may appear anytime after the first day of life and persist beyond 7 days. Serum bilirubin levels are greater than 12 mg/dl in a term infant, 15 mg/dl in a premature infant, or increase more than 5 mg/dl in 24 hours. Physiologic jaundice is self-limiting; pathologic jaundice varies, depending on the cause.

CULTURAL DIVERSITY Hyperbilirubinia tends to be more common and more severe in Chinese, Japanese, Koreans, and Native Americans, whose mean peak of unconjugated bilirubin is approximately twice that of the rest of the population.

Causes

Causes may include:

Pathophysiology

As erythrocytes break down at the end of their neonatal life cycle, hemoglobin separates into globin (protein) and heme (iron) fragments. Heme fragments form unconjugated (indirect) bilirubin, which binds to albumin for transport to liver cells to conjugate with glucuronide, forming direct bilirubin. Because unconjugated bilirubin is fat-soluble and can't be excreted in the urine or bile, it may escape to extravascular tissue, especially fatty tissue and the brain, causing hyperbilirubinemia.

Certain drugs (such as aspirin, tranquilizers, and sulfonamides) and conditions (such as hypothermia, anoxia, hypoglycemia, and hypoalbuminemia) can disrupt conjugation and usurp albumin-binding sites.

Decreased hepatic function also reduces bilirubin conjugation. Biliary obstruction or hepatitis can cause hyperbilirubinemia by blocking normal bile flow.

Increased erythrocyte production or breakdown in hemolytic disorders, or in Rh or ABO incompatibility can cause hyperbilirubinemia. Lysis releases bilirubin and stimulates cell agglutination. As a result, the liver's capacity to conjugate bilirubin becomes overloaded.

Finally, maternal enzymes in breast milk inhibit the infant's glucuronyl-transferase conjugating activity.

Signs and symptoms

Complications

Diagnosis

Treatment

Irritable bowel syndrome

Also referred to as spastic colon or spastic colitis, irritable bowel syndrome (IBS) is marked by chronic symptoms of abdominal pain, alternating constipation and diarrhea, excess flatus, a sense of incomplete evacuation, and abdominal distention. Irritable bowel syndrome is a common, stress-related disorder. However, 20% of patients never seek medical attention. IBS is a benign condition that has no anatomical abnormality or inflammatory component. It occurs in women twice as often as men.

Causes

WHAT HAPPENS IN IRRITABLE BOWEL SYNDROME

Typically, the patient with irritable bowel syndrome has a normal-appearing GI tract. However, careful examination of the colon may reveal functional irritability ― an abnormality in colonic smooth-muscle function marked by excessive peristalsis and spasms, even during remission.

INTESTINAL FUNCTION

To understand what happens in irritable bowel syndrome, consider how smooth muscle controls bowel function. Normally, segmental muscle contractions mix intestinal contents while peristalsis propels the contents through the GI tract. Motor activity is most propulsive in the proximal (stomach) and the distal (sigmoid) portions of the intestine. Activity in the rest of the intestines is slower, permitting nutrient and water absorption.

In irritable bowel syndrome, the autonomic nervous system, which innervates the large intestine, doesn't cause the alternating contractions and relaxations that propel stools smoothly toward the rectum.

The result is constipation or diarrhea or both.

CONSTIPATION

Some patients have spasmodic intestinal contractions that set up a partial obstruction by trapping gas and stools. This causes distention, bloating, gas pain, and constipation.

DIARRHEA

Other patients have dramatically increased intestinal motility. Usually eating or cholinergic stimulation triggers the small intestine's contents to rush into the large intestine, dumping watery stools and irritating the mucosa. The result is diarrhea.

MIXED SYMPTOMS

If further spasms trap liquid stools, the intestinal mucosa absorbs water from the stools, leaving them dry, hard, and difficult to pass. The result: a pattern of alternating diarrhea and constipation.

Pathophysiology

Irritable bowel syndrome appears to reflect motor disturbances of the entire colon in response to stimuli. Some muscles of the small bowel are particularly sensitive to motor abnormalities and distention; others are particularly sensitive to certain foods and drugs. The patient may be hypersensitive to the hormones gastrin and cholecystokinin. The pain of IBS seems to be caused by abnormally strong contractions of the intestinal smooth muscle as it reacts to distention, irritants, or stress. (See What happens in irritable bowel syndrome .)

Signs and symptoms

Diagnosis

Treatment

Treatment may include:

Liver failure

Liver failure can be the end result of any liver disease. The liver performs over 100 separate functions in the body. When it fails, a complex syndrome involving the impairment of many different organs and body functions ensues. (See Functions of the liver .) Hepatic encephalopathy and hepatorenal syndrome are two conditions occurring in liver failure. The only cure for liver failure is a liver transplant.

Causes

Pathophysiology

Manifestations of liver failure include hepatic encephalopathy and hepatorenal syndrome.

Hepatic encephalopathy, a set of central nervous system disorders, results when the liver can no longer detoxify the blood. Liver dysfunction and collateral vessels that shunt blood around the liver to the systemic circulation permit toxins absorbed from the GI tract to circulate freely to the brain. Ammonia is one of the main toxins causing hepatic encephalopathy. Ammonia is a byproduct of protein metabolism. The normal liver transforms ammonia to urea, which the kidneys excrete. When the liver fails and is no longer able to transform ammonia to urea, ammonia blood levels rise and the ammonia is delivered to the brain. Short-chain fatty acids, serotonin, tryptophan, and false neurotransmitters may also accumulate in the blood and contribute to hepatic encephalopathy.

Hepatorenal syndrome is renal failure concurrent with liver disease; the kidneys appear to be normal but abruptly cease functioning. It causes expanded blood volume, accumulation of hydrogen ions, and electrolyte disturbances. It is most common in patients with alcoholic cirrhosis or fulminating hepatitis. The cause may be the accumulation of vasoactive substances that cause inappropriate constriction of renal arterioles, leading to decreased glomerular filtration and oliguria. The vasoconstriction may also be a compensatory response to portal hypertension and the pooling of blood in the splenic circulation.

Signs and symptoms

Complications

Diagnosis

FUNCTIONS OF THE LIVER

The liver is one of the most essential organs of the body. To understand how liver disease affects the body, it is best to understand its main functions:

  • Detoxifies poisonous chemicals, including alcohol, beer, wine, and drugs (prescribed and over-the-counter, as well as illegal substances)
  • Makes bile to help digest food
  • Stores energy by stockpiling sugar (carbohydrates, glucose, and fat) until needed
  • Stores iron reserves, as well as vitamins and minerals
  • Manufactures new proteins
  • Produces important plasma proteins necessary for blood coagulation, including prothrombin and fibrinogen
  • Serves as a site for hematopoiesis during fetal development.

Treatment

Treatment may include:

For ascites , treatment includes:

For portal hypertension , treament includes:

For variceal bleeding , treatment includes:

Malabsorption

Malabsorption is failure of the intestinal mucosa to absorb single or multiple nutrients efficiently. Absorption of amino acids, fat, sugar, or vitamins may be impaired. The result is inadequate movement of nutrients from the small intestine to the bloodstream or lymphatic system. Manifestations depend primarily on what is not being absorbed.

Causes

A wide variety of disorders result in malabsorption. (See Causes of malabsorption .)

Pathophysiology

The small intestine's inability to absorb nutrients efficiently may result from a variety of disease processes. The mechanism of malabsorption depends on the cause. Some common causes of malabsorption syndrome include celiac disease, lactase deficiency, gastrectomy, Zollinger-Ellison syndrome, and bacterial overgrowth in the duodenal stump.

In celiac sprue, dietary gluten ― a product of wheat, barley, rye, and oats ― is toxic to the patient, causing injury to the mucosal villi. The mucosa appear flat and have lost absorptive surface. Symptoms generally disappear when gluten is removed from the diet.

Lactase deficiency is a disaccharide deficiency syndrome. Lactase is an intestinal enzyme that splits nonabsorbable lactose (a disaccharide) into the absorbable monosaccharides glucose and galactose. Production may be deficient, or another intestinal disease may inhibit the enzyme.

Malabsorption may occur after gastrectomy. Poor mixing of chyme with gastric secretions is the cause of postsurgical malabsorption.

In Zollinger-Ellison syndrome, increased acidity in the duodenum inhibits release of cholecystokinin, which stimulates pancreatic enzyme secretion. Pancreatic enzyme deficiency leads to decreased breakdown of nutrients and malabsorption.

Bacterial overgrowth in the duodenal stump (loop created in the Billroth II procedure) causes malabsorption of vitamin B 12 .

Signs and symptoms

Signs and symptoms include:

CAUSES OF MALABSORPTION

Many disorders ― from systemic to organ-specific diseases ― may give rise to malabsorption.

DISEASES OF THE SMALL INTESTINE

Primary small bowel disease

  • Bacterial overgrowth due to stasis in afferent loop after Billroth II gastrectomy
  • Massive bowel resection
  • Nontropical sprue (celiac disease)
  • Regional enteritis
  • Tropical sprue

Ischemic small bowel disease

  • Chronic congestive heart failure
  • Mesenteric atherosclerosis

Small bowel infections and infestations

  • Acute enteritis
  • Giardiasis

Systemic disease involving small bowel

  • Amyloidosis
  • Lymphoma
  • Sarcoidosis
  • Scleroderma
  • Whipple's disease

DRUG-INDUCED MALABSORPTION

  • Calcium carbonate
  • Neomycin
HEPATOBILIARY DISEASE
  • Biliary fistula
  • Biliary tract obstruction
  • Cirrhosis and hepatitis

HEREDITARY DISORDER

  • Primary lactase deficiency

PANCREATIC DISORDERS

  • Chronic pancreatitis
  • Cystic fibrosis
  • Pancreatic cancer
  • Pancreatic resection
  • Zollinger-Ellison syndrome

PREVIOUS GASTRIC SURGERY

  • Billroth II gastrectomy
  • Pyloroplasty
  • Total gastrectomy
  • Vagotomy

Complications

Diagnosis

Treatment

Pancreatitis

Pancreatitis, inflammation of the pancreas, occurs in acute and chronic forms and may be due to edema, necrosis, or hemorrhage. In men, this disease is commonly associated with alcoholism, trauma, or peptic ulcer; in women, with biliary tract disease. The prognosis is good in pancreatitis associated with biliary tract disease, but poor when associated with alcoholism. Mortality is as high as 60% when pancreatitis is associated with necrosis and hemorrhage.

Causes

Pathophysiology

Acute pancreatitis occurs in two forms: edematous (interstitial) and necrotizing. Edematous pancreatitis causes fluid accumulation and swelling. Necrotizing pancreatitis causes cell death and tissue damage. The inflammation that occurs with both types is caused by premature activation of enzymes, which causes tissue damage.

Normally, the acini in the pancreas secrete enzymes in an inactive form. Two theories explain why enzymes become prematurely activated.

In one view, a toxic agent such as alcohol alters the way the pancreas secretes enzymes. Alcohol probably increases pancreatic secretion, alters the metabolism of the acinar cells, and encourages duct obstruction by causing pancreatic secretory proteins to precipitate.

Another theory is that a reflux of duodenal contents containing activated enzymes enters the pancreatic duct, activating other enzymes and setting up a cycle of more pancreatic damage.

In chronic pancreatitis, persistent inflammation produces irreversible changes in the structure and function of the pancreas. It sometimes follows an episode of acute pancreatitis. Protein precipitates block the pancreatic duct and eventually harden or calcify. Structural changes lead to fibrosis and atrophy of the glands. Growths called pseudocysts contain pancreatic enzymes and tissue debris. An abscess results if pseudocysts become infected.

If pancreatitis damages the islets of Langerhans, diabetes mellitus may result. Sudden severe pancreatitis causes massive hemorrhage and total destruction of the pancreas, manifested as diabetic acidosis, shock, or coma.

Signs and symptoms

Complications

Diagnosis

Treatment

Treatment may include:

A CLOSER LOOK AT PEPTIC ULCERS

A gastrointestinal lesion is not necessarily an ulcer. Lesions that don't extend below the mucosal lining (epithelium) are called erosions. Lesions of both acute and chronic ulcers can extend through the epithelium and perforate the stomach wall. Chronic ulcers also have scar tissue at the base.

<center></center>

Peptic ulcer

Peptic ulcers, circumscribed lesions in the mucosal membrane extending below the epithelium, can develop in the lower esophagus, stomach, pylorus, duodenum, or jejunum. Although erosions are often referred to as ulcers, erosions are breaks in the mucosal membranes that do not extend below the epithelium. Ulcers may be acute or chronic in nature. Chronic ulcers are identified by scar tissue at their base. (See A closer look at peptic ulcers .) About 80% of all peptic ulcers are duodenal ulcers, which affect the proximal part of the small intestine and occur most commonly in men between ages 20 and 50. Duodenal ulcers usually follow a chronic course with remissions and exacerbations; 5% to 10% of patients develop complications that necessitate surgery.

Gastric ulcers are most common in middle-aged and elderly men, especially in chronic users of nonsteroidal anti-inflammatory drugs, alcohol, or tobacco.

Causes

Pathophysiology

Although the stomach contains acidic secretions that can digest substances, intrinsic defenses protect the gastric mucosal membrane from injury. A thick, tenacious layer of gastric mucus protects the stomach from autodigestion, mechanical trauma, and chemical trauma. Prostaglandins provide another line of defense. Gastric ulcers may be a result of destruction of the mucosal barrier.

The duodenum is protected from ulceration by the function of Brunner's glands. These glands produce a viscid, mucoid, alkaline secretion that neutralizes the acid chyme. Duodenal ulcers appear to result from excessive acid protection. Helicobacter pylori releases a toxin that destroys the gastric and duodenal mucosa, reducing the epithelium's resistance to acid digestion and causing gastritis and ulcer disease.

Salicylates and other NSAIDs inhibit the secretion of prostaglandins (substances that block ulceration). Certain illnesses, such as pancreatitis, hepatic disease, Crohn's disease, preexisting gastritis, and Zollinger-Ellison syndrome, also contribute to ulceration.

Besides peptic ulcer's main causes, several predisposing factors are acknowledged. They include blood type (gastric ulcers and type A; duodenal ulcers and type O) and other genetic factors. Exposure to irritants, such as alcohol, coffee, and tobacco, may contribute by accelerating gastric acid emptying and promoting mucosal breakdown. Emotional stress also contributes to ulcer formation because of the increased stimulation of acid and pepsin secretion and decreased mucosal defense. Physical trauma and normal aging are additional predisposing conditions.

Signs and symptoms

Symptoms vary by the type of ulcer.

A gastric ulcer produces the following signs and symptoms:

A duodenal ulcer produces the following signs and symptoms:

Complications

Diagnosis

Treatment

Treating peptic ulcer

Peptic ulcers can result from factors that increase gastric acid production or from factors that impair mucosal barrier protection. This illustration highlights the actions of the major treatments used for peptic ulcer and where they interfere with the pathophysiologic chain of events.

<center></center>

Ulcerative colitis

Ulcerative colitis is an inflammatory, often chronic, disease that affects the mucosa of the colon. It invariably begins in the rectum and sigmoid colon, and commonly extends upward into the entire colon, rarely affecting the small intestine, except for the terminal ileum. Ulcerative colitis produces edema (leading to mucosal friability) and ulcerations. Severity ranges from a mild, localized disorder to a fulminant disease that may cause a perforated colon, progressing to potentially fatal peritonitis and toxemia. The disease cycles between exacerbation and remission.

Ulcerative colitis occurs primarily in young adults, especially women. It's more prevalent among Ashkenazic Jews and in higher socioeconomic groups, and there seems to be a familial tendency. The prevalence is unknown; however, some studies suggest as many as 100 of 100,000 persons have the disease. Onset of symptoms seems to peak between ages 15 and 30 and between ages 55 and 65.

Causes

Specific causes of ulcerative colitis are unknown but may be related to abnormal immune response in the GI tract, possibly associated with food or bacteria such as Escherichia coli .

Pathophysiology

Ulcerative colitis usually begins as inflammation in the base of the mucosal layer of the large intestine. The colon's mucosal surface becomes dark, red, and velvety. Inflammation leads to erosions that coalesce and form ulcers. The mucosa becomes diffusely ulcerated, with hemorrhage, congestion, edema, and exudative inflammation. Ulcerations are continuous. Abscesses in the mucosa drain purulent pus, become necrotic, and ulcerate. Sloughing causes bloody, mucus filled stools. As abscesses heal, scarring and thickening may appear in the bowel's inner muscle layer. As granulation tissue replaces the muscle layer, the colon narrows, shortens, and loses its characteristic pouches (haustral folds).

Signs and symptoms

Signs and symptoms may include:

Complications

Complications may include:

Diagnosis

Treatment

Treatment includes:

提问
扫一扫
丁香实验小程序二维码
实验小助手
丁香实验公众号二维码
扫码领资料
反馈
TOP
打开小程序